@inproceedings{oai:repo.qst.go.jp:00054278,
 author = {Kamada, Tadashi and Imai, Reiko and Tsuji, Hiroshi and Imaizumi, Takeshi and Matsunobu, Akira and Okada, Tohru and Tsujii, Hirohiko and 鎌田 正 and 今井 礼子 and 辻 比呂志 and 今泉 猛 and 松延 亮 and 岡田 徹 and 辻井 博彦},
 book = {Proceedings of Japanease-European Joint Symposium on Ion Cancer Therapy and NIRS-KI Joint Symposium on Ion-Radiation Sciences, September 9 & 10-11, 2010 Karolinska University Hospital, Solna Stockholm, Sweden Organized by National Institute of Radiological Sciences, Japan and Karolinska Institute, Sweden},
 issue = {235},
 month = {},
 note = {The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world first heavy ion accelerator complex dedicated to medical use in a hospital environment. Carbon ion therapy offers the potential advantages of improved dose localization and enhanced biological effects. It has been suggested that carbon ion therapy is effective against radioresistant pancreatic cancer. In April 2000, clinical studies examining the treatment of pancreatic cancer with carbon ions were begun at the HIMAC. As of February 2010, 48 patients treated with preoperative carbon ion radiotherapy and 89 patients treated for locally advanced pancreatic cancer were enrolled into the clinical trials. Both protocols are still ongoing. The interim results of these clinical trials suggest that carbon ion radiotherapy provides good local control and offers a survival advantage for patients with otherwise hard to cure pancreatic cancer, without unacceptable morbidity.},
 pages = {74--84},
 publisher = {National Institute of Radiological Sciences},
 title = {Carbon Ion Radiotherapy in Bone and Soft Tssue Sarcomas},
 volume = {NIRS-M},
 year = {2010}
}